Benzinga | Aug 6, 2020 04:28PM EDT

CTI BioPharma Q2 EPS $(0.19), Same YoY

CTI BioPharma (NASDAQ:CTIC) reported quarterly losses of $(0.19) per share. This is unchanged from the same period last year.